可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Enas A. Lipoprotein(a) as a determinant of coronary heart disease in young women: a stronger risk factor than diabetes?[J]. Circulation, 1998, 97(3):293-295.
[2]Bello N, Mosca L. Epidemiology of coronary heart disease in women[J]. Prog Cardiovasc Dis, 2004, 46(4):287-295.
[3]Kurita A, Takase B, Uehata A, et al. Painless myocardial ischemia in elderly patients compared with middle-aged patients and its relation to treadmill testing and coronary hemodynamics[J]. Clin Cardiol, 1991, 14(11):886-890.
[4]Mosea L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women[J]. Circulation, 2004, 109(5):672-693.
[5]Mosea L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update[J]. Circulation, 2007, 115(11):1481-1501.
[6]Kannel WB. CHD risk faetors: a Framingham study update[J]. Hosp Praet (Off Ed), 1990, 25(7):119-127.
[7] Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey[J]. Rheumatology (Oxford), 2008, 47(5):713-717.
[8]Swan HJ, Gersh BJ, Graboys TB, et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 7. Evaluation and management of risk factors for the individual patient (case management)[J]. J Am Coll Cardiol, 1996, 27(5):1030-1039.